{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:32:13Z","timestamp":1790087533017,"version":"4.0.1"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006342","name":"Association Vaincre la Mucoviscidose","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cystic fibrosis (CF) care and the life expectancy of affected patients have substantially improved in recent decades, leading to an increased number of patients being diagnosed with comorbidities, including cancers. Our objective was to characterize the epidemiology of cancers between 2006 and 2017 in CF patients with and without a lung transplant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Medical records of CF patients from 2006 to 2016 in the French CF Registry were linked to their corresponding claims data (SNDS). The annual prevalence and incidence rates of cancers were estimated from 2006 to 2017 in CF patients without lung transplant and in those with lung transplant after transplantation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 7,671 patients included in the French CF Registry, 6,187 patients (80.7%) were linked to the SNDS; among them, 1,006 (16.3%) received a lung transplant. The prevalence of any cancer increased between 2006 and 2017, from 0.3 to 1.0% and from 1.3 to 6.3% in non-transplanted and transplanted patients, respectively. When compared to the general population, the incidence of cancer was significantly higher in both non-transplanted [Standardized Incidence Ratio (SIR) = 2.57, 95%CI 2.05 to 3.17] and transplanted (SIR = 19.76, 95%CI 16.45 to 23.55) patients. The median time between transplant and the first cancer was 3.9 years. Among the 211 incident cancer cases, the most frequent malignant neoplasms were skin neoplasm (48 cases), lung cancers (31 cases), gastro-intestinal (24 cases), and hematologic cancers (17 cases).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The overall burden of cancer in CF patients is high, particularly following lung transplantation. Therefore, specific follow-up, screening and cancer prevention for CF patients with transplants are necessary.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2022.1043691","type":"journal-article","created":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T03:05:57Z","timestamp":1669086357000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Cancer incidence and prevalence in cystic fibrosis patients with and without a lung transplant in France"],"prefix":"10.3389","volume":"10","author":[{"given":"Christine","family":"Rousset-Jablonski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faustine","family":"Dalon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quitterie","family":"Reynaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydie","family":"Lemonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence","family":"Dehillotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flore","family":"Jacoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie","family":"Berard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Viprey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Van Ganse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Durieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Belhassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1183\/13993003.00592-2015","article-title":"Report of the European Respiratory Society\/European Cystic Fibrosis Society task force on the care of adults with cystic fibrosis","volume":"47","author":"Elborn","year":"2016","journal-title":"Eur Respir J."},{"key":"B2","year":"2022","journal-title":"French Cystic Fibrosis Registry - Annual Data Report 2020. Registre Fran\u00e7ais de la Mucoviscidose \u2013 Bilan des Donn\u00e9es 2020"},{"key":"B3","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/jnci\/djs481","article-title":"Cancer risk in cystic fibrosis: a 20-year nationwide study from the United States","volume":"105","author":"Maisonneuve","year":"2013","journal-title":"J Natl Cancer Inst."},{"key":"B4","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJM199502233320803","article-title":"The risk of cancer among patients with cystic fibrosis","volume":"332","author":"Neglia","year":"1995","journal-title":"N Engl J Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11894-017-0546-0","article-title":"The enigmatic gut in cystic fibrosis: linking inflammation, dysbiosis, and the increased risk of malignancy","volume":"19","author":"Garg","year":"2017","journal-title":"Curr Gastroenterol Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ccm.2015.11.004","article-title":"Gastrointestinal disorders in cystic fibrosis","volume":"37","author":"Assis","year":"2016","journal-title":"Clin Chest Med."},{"key":"B7","year":"2020","journal-title":"2018 Annual Report From the European Cystic Fibrosis Society Patient Registry"},{"key":"B8","volume-title":"Cystic Fibrosis Foundation Patient Registry: 2019 Annual Data Report","year":"2020"},{"key":"B9","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/jnci\/95.5.381","article-title":"Cancer risk in nontransplanted and transplanted cystic fibrosis patients: a 10-year study","volume":"95","author":"Maisonneuve","year":"2003","journal-title":"J Natl Cancer Inst."},{"key":"B10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jcf.2016.07.011","article-title":"Cancer risk among lung transplant recipients with cystic fibrosis","volume":"16","author":"Fink","year":"2017","journal-title":"J Cystic Fibrosis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.3390\/ijms21082891","article-title":"Cystic fibrosis, CFTR, and colorectal cancer","volume":"21","author":"Scott","year":"2020","journal-title":"IJMS."},{"key":"B12","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jcf.2021.07.004","article-title":"Incidence and risk factors of cancer in individuals with cystic fibrosis in the UK; a case-control study","volume":"21","author":"Archangelidi","year":"2021","journal-title":"J Cystic Fibrosis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1002\/ijc.24679","article-title":"Cancer risk among patients with cystic fibrosis and their first-degree relatives","volume":"125","author":"Johannesson","year":"2009","journal-title":"Int J Cancer."},{"key":"B14","doi-asserted-by":"publisher","first-page":"S149","DOI":"10.1016\/j.respe.2017.05.004","article-title":"Value of a national administrative database to guide public decisions: From the syst\u00e8me national d'information interr\u00e9gimes de l'Assurance Maladie (SNIIRAM) to the syst\u00e8me national des donn\u00e9es de sant\u00e9 (SNDS) in France","volume":"65","author":"Tuppin","year":"2017","journal-title":"Rev Epidemiol Sante Publique."},{"key":"B15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jcf.2021.03.025","article-title":"Temporal trends in healthcare resource use and associated costs of patients with cystic fibrosis","volume":"21","author":"Durieu","year":"2022","journal-title":"J Cyst Fibros."},{"key":"B16","unstructured":"Estimations Nationales de l'incidence et de la Mortalit\u00e9 par Cancer en France M\u00e9tropolitaine Entre 1990 et 2018. Saint-Maurice : Sant\u00e9 Publique France372\n            DefossezG\n            Le Guyader-PeyrouS\n            UhryZ\n            GrosclaudeP\n            ColonnaM\n            DantonyE\n          2019"},{"key":"B17","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S1470-2045(18)30188-8","article-title":"Risk of gastrointestinal cancers in patients with cystic fibrosis: a systematic review and meta-analysis","volume":"19","author":"Yamada","year":"2018","journal-title":"Lancet Oncol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1053\/j.gastro.2017.12.012","article-title":"Cystic fibrosis colorectal cancer screening consensus recommendations","volume":"154","author":"Hadjiliadis","year":"2018","journal-title":"Gastroenterology."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e13269","DOI":"10.1111\/ctr.13269","article-title":"Long-term extrapulmonary comorbidities after lung transplantation in cystic fibrosis: update of specificities","volume":"32","author":"Jardel","year":"2018","journal-title":"Clin Transplant."},{"key":"B20","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1097\/01.TP.0000436907.56425.5c","article-title":"Predictors of cancer risk in the long-term solid-organ transplant recipient","volume":"97","author":"Sherston","year":"2014","journal-title":"Transplantation."},{"key":"B21","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1080\/17476348.2019.1638768","article-title":"Extra-respiratory comorbidities and transplantation in the French cystic fibrosis registry","volume":"13","author":"Mainbourg","year":"2019","journal-title":"Expert Rev Respir Med."},{"key":"B22","author":"Haute","year":"2013","journal-title":"R\u00e9f\u00e9rentiel de Pratiques Pour la Pr\u00e9vention et le D\u00e9pistage du Cancer du col de L'ut\u00e9rus"},{"key":"B23","author":"Haute","year":"2019","journal-title":"Evaluation de la Recherche des Papillomavirus Humains (HPV) en D\u00e9pistage Primaire des L\u00e9sions Pr\u00e9canc\u00e9reuses et Canc\u00e9reuses du col de L'ut\u00e9rus et de la Place du Double Immuno-Marquage p16\/Ki67"},{"key":"B24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/ajt.13978","article-title":"Cancer screening recommendations for solid organ transplant recipients: a systematic review of clinical practice guidelines","volume":"17","author":"Acuna","year":"2017","journal-title":"Am J Transplant."},{"key":"B25","doi-asserted-by":"publisher","first-page":"101242","DOI":"10.1016\/j.rmcr.2020.101242","article-title":"Primary lung carcinoma in cystic fibrosis: a case report and literature review","volume":"31","author":"Patel","year":"2020","journal-title":"Respir Med Case Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1136\/bmj.302.6779.760","article-title":"Frequency of carriers of cystic fibrosis gene among patients with myeloid malignancy and melanoma","volume":"302","author":"Warren","year":"1991","journal-title":"BMJ."},{"key":"B27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/(SICI)1098-1004(1997)10:1<45::AID-HUMU6>3.0.CO;2-L","article-title":"The cystic fibrosis delta F508 gene mutation and cancer","volume":"10","author":"Padua","year":"1997","journal-title":"Hum Mutat."},{"key":"B28","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/jgh.12842","article-title":"Elevated fecal M2-pyruvate kinase in children with cystic fibrosis: a clue to the increased risk of intestinal malignancy in adulthood?","volume":"30","author":"Pang","year":"2015","journal-title":"J Gastroenterol Hepatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1126\/science.1224820","article-title":"Intestinal inflammation targets cancer-inducing activity of the microbiota","volume":"338","author":"Arthur","year":"2012","journal-title":"Science."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1038\/onc.2017.3","article-title":"CFTR is a tumor suppressor gene in murine and human intestinal cancer","volume":"36","author":"Than","year":"2017","journal-title":"Oncogene."},{"key":"B31","first-page":"43","article-title":"Cumulative radiation exposure in children with cystic fibrosis","volume":"103","author":"O'Reilly","year":"2010","journal-title":"Ir Med J."},{"key":"B32","first-page":"29","article-title":"Radiation risks from pediatric computed tomography scanning","volume":"7","author":"Chodick","year":"2009","journal-title":"Pediatr Endocrinol Rev."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.1043691\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T03:06:06Z","timestamp":1669086366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.1043691\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":32,"alternative-id":["10.3389\/fpubh.2022.1043691"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2022.1043691","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,22]]},"article-number":"1043691"}}